Sand Hill Global Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.85M Sell
35,549
-1,144
-3% -$316K 0.24% 56
2026
Q1
$10.8M Sell
36,693
-567
-2% -$168K 0.36% 39
2025
Q4
$10.2M Sell
37,260
-851
-2% -$231K 0.36% 38
2025
Q3
$10.3M Sell
38,111
-944
-2% -$257K 0.36% 41
2025
Q2
$10.8M Buy
39,055
+594
+2% +$162K 0.4% 35
2025
Q1
$10.2M Sell
38,461
-265
-0.7% -$65.4K 0.42% 35
2024
Q4
$8.99M Sell
38,726
-998
-3% -$229K 0.38% 39
2024
Q3
$8.77M Sell
39,724
-714
-2% -$148K 0.37% 44
2024
Q2
$7.95M Sell
40,438
-3
-0% -$620 0.36% 44
2024
Q1
$8.71M Sell
40,441
-4,868
-11% -$1.02M 0.41% 40
2023
Q4
$9.54M Sell
45,309
-139
-0.3% -$29.7K 0.46% 36
2023
Q3
$9.1M Buy
45,448
+62
+0.1% +$12.3K 0.5% 31
2023
Q2
$8.41M Buy
45,386
+451
+1% +$83.3K 0.42% 36
2023
Q1
$8.61M Sell
44,935
-63
-0.1% -$11.4K 0.46% 32
2022
Q4
$7.57M Buy
44,998
+212
+0.5% +$36.8K 0.43% 41
2022
Q3
$7.93M Sell
44,786
-949
-2% -$188K 0.5% 30
2022
Q2
$9.36M Sell
45,735
-1,707
-4% -$362K 0.53% 30
2022
Q1
$11.3M Buy
47,442
+929
+2% +$218K 0.62% 23
2021
Q4
$10.6M Sell
46,513
-401
-0.9% -$88.2K 0.6% 25
2021
Q3
$9.07M Buy
46,914
+4,509
+11% +$914K 0.55% 26
2021
Q2
$9.02M Buy
42,405
+1,106
+3% +$234K 0.55% 26
2021
Q1
$8.43M Buy
41,299
+2,390
+6% +$471K 0.55% 27
2020
Q4
$7.08M Buy
38,909
+977
+3% +$166K 0.47% 32
2020
Q3
$6.35M Sell
37,932
-524
-1% -$88.3K 0.48% 33
2020
Q2
$6.25M Buy
38,456
+189
+0.5% +$33.9K 0.5% 32
2020
Q1
$6.62M Buy
38,267
+354
+0.9% +$70.5K 0.63% 22
2019
Q4
$7.61M Buy
37,913
+1,345
+4% +$276K 0.69% 23
2019
Q3
$7.73M Sell
36,568
-1,429
-4% -$299K 0.72% 21
2019
Q2
$7.38M Sell
37,997
-562
-1% -$104K 0.76% 20
2019
Q1
$6.35M Sell
38,559
-830
-2% -$147K 0.65% 23
2018
Q4
$7.41M Sell
39,389
-689
-2% -$127K 0.8% 22
2018
Q3
$6.82M Sell
40,078
-666
-2% -$112K 0.65% 26
2018
Q2
$6.68M Buy
40,744
+37,678
+1,229% +$6.15M 0.66% 23
2018
Q1
$496K Sell
3,066
-38,508
-93% -$6.13M 0.48% 45
2017
Q4
$6.07M Sell
41,574
-1,871
-4% -$266K 0.6% 28
2017
Q3
$5.89M Buy
43,445
+271
+0.6% +$34.2K 0.63% 29
2017
Q2
$5.41M Buy
43,174
+1,178
+3% +$141K 0.62% 32
2017
Q1
$4.99M Buy
41,996
+625
+2% +$75.2K 0.65% 30
2016
Q4
$4.77M Buy
41,371
+36
+0.1% +$4.01K 0.66% 30
2016
Q3
$4.32M Sell
41,335
-1,531
-4% -$160K 0.66% 33
2016
Q2
$4.17M Buy
42,866
+611
+1% +$57.7K 0.66% 35
2016
Q1
$4.06M Buy
42,255
+694
+2% +$63.1K 0.62% 37
2015
Q4
$3.77M Sell
41,561
-425
-1% -$40K 0.6% 39
2015
Q3
$3.89M Buy
41,986
+7
+0% +$665 0.62% 34
2015
Q2
$3.91M Buy
41,979
+2,058
+5% +$192K 0.64% 35
2015
Q1
$3.78M Sell
39,921
-3,606
-8% -$334K 0.62% 38
2014
Q4
$3.86M Sell
43,527
-4,942
-10% -$419K 0.66% 34
2014
Q3
$3.88M Buy
48,469
+3,759
+8% +$283K 0.64% 38
2014
Q2
$3.17M Buy
44,710
+1,796
+4% +$126K 0.6% 42
2014
Q1
$3.18M Buy
42,914
+1,105
+3% +$83.4K 0.64% 39
2013
Q4
$3.28M Sell
41,809
-15,460
-27% -$1.21M 0.7% 38
2013
Q3
$4.23M Buy
57,269
+16,290
+40% +$1.2M 0.73% 31
2013
Q2
$3.11M Buy
+40,979
New +$2.69M 0.86% 26

Other funds holding CME

Sand Hill Global Advisors's CME Position: Q2 2026 in Review

Sand Hill Global Advisors reduced its CME Group (CME) stake by 3.1% in Q2 2026, selling an estimated $316K and leaving 35,549 shares worth $7.85M. The position accounts for 0.24% of the portfolio, ranked #56.

Sand Hill Global Advisors first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.3M in Q1 2022. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Sand Hill Global Advisors held 35,549 shares of CME Group worth $7.85M as of Q2 2026.
  • Sand Hill Global Advisors sold 1,144 CME Group shares in Q2 2026, an estimated $316K.
  • CME Group made up 0.24% of Sand Hill Global Advisors's portfolio in Q2 2026, its #56 holding.
  • Sand Hill Global Advisors first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • Sand Hill Global Advisors's CME Group position peaked at $11.3M in Q1 2022.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Sand Hill Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.